Complete reference ranges for pulmonary function tests from a single New Zealand population

New Zealand Medical Journal

Volumn 119, Issue 1244, 2006, Pages

  Marsh, Suzanne ^a   Aldington, Sarah ^a   Williams, Mathew ^a   Weatherall, Mark ^b   Shirtcliffe, Philippa ^a   McNaughton, Amanda ^a   Pritchard, Alison ^a   Beasley, Richard ^a  

^a MEDICAL RESEARCH INSTITUTE OF NEW ZEALAND   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AIRWAY RESISTANCE; ARTICLE; CIGARETTE SMOKING; COHORT ANALYSIS; CONTROLLED STUDY; EUROPE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN EXPERIMENT; LINEAR REGRESSION ANALYSIS; LUNG FUNCTION TEST; LUNG VOLUME; MALE; MEDICAL SOCIETY; NEW ZEALAND; NORMAL HUMAN; POPULATION RESEARCH; PREDICTOR VARIABLE; REFERENCE VALUE; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT PARAMETERS; SEX DIFFERENCE; SPIROMETRY; SYMPTOMATOLOGY; TOTAL LUNG CAPACITY; UNIVARIATE ANALYSIS; VITAL CAPACITY;

EID: 84859673376     PISSN: 11758716     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Crapo R. The role of reference values in interpreting lung function tests. Eur Respir J. 2004;24:341-2.
2. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of COPD; 2005. URL: http://www.goldcopd.com
3. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2004 update. URL: http://www.ginasthma.com
4. Pellegrino R, Viegi G, Brusasco V, et al. ATS/ERS Task Force: Standardisation of lung function testing. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948-68.
5. Roberts C, MacRae K, Winning A, et al. Reference values and prediction equations for normal lung function in a non-smoking white urban population. Thorax. 1991;46:643-50.
6. Roca J, Sanchis J, Agusti-Vidal A, et al. Spirometric reference values from a Mediterranean population. Bull Eur Physiopathol Respir. 1986;22:217-24.
7. Roca J, Rodriguez-Roisin R, Cobo E, et al. Single-breath Carbon Monoxide diffusing capacity prediction equations from a Mediterranean population. Am Rev Resp Dis. 1990;141:1026-32.
8. Roca J, Burgos F, Barbera J, et al. Prediction equations for plethysmographic lung volumes. Respiratory Medicine. 1998;92(3):454-60.
9. Sinclair SW, Avery SF, Brady D, et al. Prediction formulae for normal pulmonary function values in New Zealand European subjects. N Z Med J. 1980;91:1-5.
10. Quanjer P, Dalhuijsen A, Van Zoramen B. Standardised Lung Function Testing. Report of the working party for the European Community for Coal and Steel. Bull Eur Physiopathol Respir. 1983;19 (suppl. 5):1-95.
11. Quanjer P, Trammeling G, Cotes J, et al. Lung volumes and forced ventilatory flows. Report of the working party for standardisation of lung function tests. European Community for Steel and Coal. Official statement of the European Respiratory Society. Eur Respir J. 1993;6(Supplement 16):s5-s40.
12. Cotes J, Chinn D, Quanjer P, et al. Standardization of the measurement of transfer factor (diffusing capacity). Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J. 1993;6(Supplement 16):s41-s52.
13. de Marco R, Accordini S, Cerveri I, et al. An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages. Thorax. 2004;59:120-5.
14. Calverley P, Burge P, Spencer S, et al. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax. 2003;58:659-64.
15. Janson C, Anto J, Burney P, et al. The European Community Respiratory Health Survey: what are the main results so far? Eur Respir J. 2001;18:598-611.
16. Roca J, Burgos F, Sunyer J, et al. Reference values for forced spirometry. Eur Respir J. 1998;11:1354-62.
17. Langhammer A, Johnsen R, Gulsvik A, et al. Forced spirometry reference values for Norwegian adults: the bronchial obstruction in Nord-Trondelag study. Eur Respir J. 2001;18:770-9.
18. Swanney M, Jensen R, Crichton D, et al. FEV6 is an acceptable surrogate for FVC in the spirometric diagnosis of airway obstruction and restriction. Am J Respir Crit Care Med. 2000;162:917-19.
19. Vandevoorde J, Verbanck S, Schuermans D, et al. FEV1/FEV6 and FEV6 as an alternative for FEV1/FVC and FVC in the spirometric detection of airway obstruction and restriction. Chest. 2005;127:1560-4.
20. American Thoracic Society. Lung function testing: Selection of reference values and interpretive strategies. Am Rev Resp Dis. 1991;144:1202-18.
21. Marsh S, Aldington S, Williams M, et al. Physiological associations of CT lung density: a factor analysis. Int J COPD. 2006;1:181-7.
22. American Thoracic Society. Standardization of Spirometry, 1994 Update. Am J Respir Crit Care Med. 1995;152:1107-36.
23. Coates A, Peslin R, Rodenstein D, et al. ERS/ATS workshop report series: Measurement of lung volumes by plethysmography. Eur Respir J. 1997;10:1415-27.
24. American Thoracic Society. Single-breath Carbon Monoxide diffusing capacity (transfer factor): Recommendations for a standard technique. Am J Respir Crit Care Med. 1995;152:2185-98.
25. Draper NR, Smith H. Applied Regression Analysis. 3rd Edition. New York: John Wiley; 1998. p332.
26. Hankinson J, Odencrantz J, Fedan K. Spirometric reference values from a sample of the general U.S population. Am J Respir Crit Care Med. 1999;159:179-87.
27. Falaschetti E, Laiho J, Primatesta P, et al. Prediction equations for normal and low lung function from the Health Survey for England. Eur Respir J. 2004;23:456-63.
28. Statistics New Zealand. New Zealand Census of Population and Dwellings 2001. URL: http://www.stats.govt.nz/default.htm
29. Garcia-Rio F, Pino J, Dorgham A, et al. Spirometric reference equations for European females and males aged 65-85 years. Eur Respir J. 2004;24:397-405.
30. Gore C, Crockett A, Pederson D, et al. Spirometric standards for healthy adult lifetime nonsmokers in Australia. Eur Respir J. 1995;8:773-82.
31. Wanger J, Clausen J, Coates A, et al. ATS/ERS Task Force: Standardisation of lung function testing. Standardisation of the measurement of lung volumes. Eur Respir J. 2005;26:511-22.
32. Dockery D, Ware J, Ferris BJ. Distribution of FEV1 and FVC in healthy white adult never smokers in six US cities. Am Rev Resp Dis. 1985;131:974-80.
33. Crapo R, Morris A, Clayton P, et al. Lung volumes in healthy non smoking adults. Bull Eur Physiopathol Respir. 1982;18:419-25.
34. Swanney M, Wallace LA, Beckert LE, et al. Selection of pulmonary function reference equations for the Christchurch population ANZSRS Annual Scientific Meeting 2005, Perth, Australia: Abstract AO12.
35. Enright P, Connett J, Bailey W. The FEV1/FEV6 predicts lung function decline in adult smokers. Respiratory Medicine. 2002;96:444-9.
36. Crapo R, Morris A. Standardised single breath normal values for carbon monoxide diffusing capacity. Am Rev Resp Dis. 1981;123:185-9.
37. Miller A, Thornton J, Warshaw R, et al. Single breath diffusing capacity in a representative sample of the population of Michigan, a large industrial state. Am Rev Resp Dis. 1983;127:270-7.
38. Neas L, Schwartz J. The determinants of pulmonary diffusing capacity in a national sample of U.S. adults. Am J Respir Crit Care Med. 1996;153:656-64.